Jefferson scientists find that plavix appears to be safe during and after heart bypass
... ... ...ESC statement on the CHARISMA trial on Clopidogrel (Plavix)
While the CHARISMA trial (Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance) results have shown no benefit overall of the combination of Clopidogrel and aspirin in the long term in stable vascular patients, and some indication of harm in patients in primary prevention, the ESC would like to remind patients that dual antiplatelet therapy is an essentia...Dangers of stopping clopidogrel (Plavix) for patients with stents and certain other conditions
Recent media reports regarding the results of the CHARISMA Trial may be misinterpreted by patients with coronary stents and other conditions*, causing these patients to inappropriately stop taking the anti-clotting drug clopidogrel (Plavix). Patients taking Plavix for any reason should consult with their cardiologist or other health care provider before stopping this medication. ...... The CHARIS...